Placental pathology, a survival guide

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 4, 2008, Pages 641-651

  Roberts, Drucilla J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; FAMILY PLANNING; FETUS DISEASE; HISTOPATHOLOGY; HUMAN; INTERVENTION STUDY; LEGAL ASPECT; MATERNAL CARE; MEDICAL INFORMATION; MEDICAL SPECIALIST; NEUROLOGIC DISEASE; NEWBORN CARE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PLACENTA DISORDER; PLACENTA PERFUSION; PRACTICE GUIDELINE; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; SURVIVAL; THROMBOSIS; VASCULAR DISEASE; VASCULITIS;

FEMALE; FETAL DISEASES; HUMANS; PATHOLOGY; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 41749104624     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Wigglesworth JS, Singer DB. Textbook of Fetal and Perinatal Pathology. Vol 1. 5th ed. London, United Kingdom: Blackwell Science; 1998:1205.
2. Mills JL, Harley EE, Moessinger AC. Standards for measuring umbilical cord length. Placenta. 1983;4:423-426.
3. Benirschke K, Kaufman P, Baergen RN. The Pathology of the Human Placenta. 5th ed. New York, NY: Springer-Verlag; 2006:1050.
4. Hecht JL, Kliman HJ, Allred EN, et al. Reference weights for placentas delivered before the 28th week of gestation. Placenta. 2007;28:987-990.
5. Lee Y, Kim KR, McKeon F, et al. A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol. 2007; 38:1003-1013.
6. Pinar H, Stephens M, Singer DB, et al. Triplet placentas: reference values for weights. Pediatr Dev Pathol. 2002;5:495-498.
7. Pinar H, Sung CJ, Oyer CE, Singer DB. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med. 1996;16:901-907.
8. Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:237-249.
9. Ogino S, Redline RW. Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol. 2000; 31:945-954.
10. Caldarella A, Buccoliero AM, Taddei GL. Chorangiosis: report of three cases and review of the literature. Pathol Res Pract. 2003;199:847-850.
11. Schwartz DA. Chorangiosis and its precursors: underdiagnosed placental indicators of chronic fetal hypoxia. Obstet Gynecol Surv. 2001;56:523-525.
12. De La Ossa MM, Cabello-lnchausti B, Robinson MJ. Placental chorangiosis. Arch Pathol Lab Med. 2001;125:1258.
13. Altshuler G. Chorangiosis. An important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med. 1984;108:71-74.
14. Raspollini MR, Oliva E, Roberts DJ. Placental histopathologic features in patients with thrombophilic mutations. J Matern Fetal Neonatal Med. 2007;20: 113-123.
15. Mandsager NT, Bendon R, Mostello D, Rosenn B, Miodovnik M, Siddiqi TA. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol. 1994;83:750-754.
16. Nickel RE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child. 1988;142:1270-1271.
17. Katz VL, Bowes WA Jr, Sierkh AE. Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein. Am J Perinatal. 1987;4:225-228.
18. Naeye RL. Maternal floor infarction. Hum Pathol. 1985;16:823-828.
19. Clewell WH, Manchester DK. Recurrent maternal floor infarction: a preventable cause of fetal death. Am J Obstet Gynecol. 1983;147:346-347.
20. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol. 2002;5:159-164.
21. Doss BJ, Greene MF, Hill J, Heffner LJ, Bieber FR, Genest DR. Massive chronic intervillositis associated with recurrent abortions. Hum Pathol. 1995;26: 1245-1251.
22. Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am J Reprod Immunol Microbiol. 1987;15:85-91.
23. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003;110:292-295.
24. Weber MA, Nikkels PG, Hamoen K, Duvekot JJ, de Krijger RR. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report. Pediatr Dev Pathol. 2006;9:234-238.
25. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995;26:80-85.
26. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol. 1999;30:759-769.
27. Kraus FT. Placenta: thrombosis of fetal stem vessels with fetal thrombotic vasculopathy and chronic villitis. Pediatr Pathol Lab Med. 1996;16:143-148.
28. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:443-452.
29. Sander CM. Update: etiology, diagnosis and management of hemorrhagic endovasculitis of the placenta. Compr Ther. 1991;17:16-19.
30. Rayburn W, Sander C, Barr M Jr, Rygiel R. The stillborn fetus: placental histologic examination in determining a cause. Obstet Gynecol. 1985;65:637-641.
31. Sander CH, Kinnane L, Stevens NG. Hemorrhagic endovasculitis of the placenta: a clinicopathologic entity associated with adverse pregnancy outcome. Compr Ther. 1985;11:66-74.
32. Stevens NG, Sander CH. Placental hemorrhagic endovasculitis: risk factors and impact on pregnancy outcome. Int J Gynaecol Obstet. 1984;22:393-397.
33. Sander CH, Stevens NG. Hemorrhagic endovasculitis of the placenta: an indepth morphologic appraisal with initial clinical and epidemiologic observations. Pathol Annu. 1984;19(pt 1):37-79.
34. Sander CH. Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. Arch Pathol Lab Med. 1980;104:371-373.
35. Altshuler G, Arizawa M, Molnar-Nadasdy G. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome. Obstet Gynecol. 1992;79:760-766.
36. Altshuler G, Hyde S. Meconium-induced vasocontraction: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol. 1989;4:137-142.
37. King EL, Redline RW, Smith SD, Kraus FT, Sadovsky Y, Nelson DM. Myocytes of chorionic vessels from placentas with meconium-associated vascular necrosis exhibit apoptotic markers. Hum Pathol. 2004;35:412-417.
38. Sander CM, Gilliland D, Richardson A, Foley KM, Fredericks J. Stillbirths with placental hemorrhagic endovasculitis: a morphologic assessment with clinical implications. Arch Pathol Lab Med. 2005;129:632-638.
39. Sander CM, Gilliland D, Akers C, McGrath A, Bismar TA, Swart-Hills LA. Livebirths with placental hemorrhagic endovasculitis: interlesional relationships and perinatal outcomes. Arch Pathol Lab Med. 2002;126:157-164.
40. Salafia CM, Pezzullo JC, Minior VK, Divon MY. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol. 1997;90:830-836.
41. Sander CM, Gilliland D, Flynn MA, Swart-Hills LA. Risk factors for recurrence of hemorrhagic endovasculitis of the placenta. Obstet Gynecol. 1997;89: 569-576.
42. Sander CM. Hemorrhagic endovasculitis of the placenta. Am J Obstet Gynecol. 1992;167:1483.
43. Owen J. Hemorrhagic endovasculitis of the placenta and fetomaternal hemorrhage: a relationship? Am J Obstet Gynecol. 1992;167:860-861.
44. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol. 1992;9:179-184.
45. Beaudet L, Karuri S, Lau J, Magee F, Lee SK, von Dadelszen P. Placental pathology and clinical outcomes in a cohort of infants admitted to a neonatal intensive care unit. J Obstet Gynaecol Can. 2007,29:315-323.
46. Redline RW. Placental pathology and cerebral palsy. Clin Perinatol. 2006; 33:503-516.
47. Redline RW. Infections and other inflammatory conditions. Semin Diagn Pathol. 2007;24:5-13.
48. Redline RW, Wilson-Costello D, Borawski E, Fanaroff AA, Hack M. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med. 1998;122:1091-1098.
49. Redline RW, Wilson-Costello D, Borawski E, Fanaroff AA, Hack M. The relationship between placental and other perinatal risk factors for neurologic impairment in very low birth weight children. Pediatr Res. 2000;47:721-726.
50. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med. 2006;11:296-301.
51. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452-457.
52. Altman JF, Lowe L, Redman B, et al. Placental metastasis of maternal melanoma. J Am Acad Dermatol. 2003;49:1150-1154.
53. Rivasi F, Gasser B, Collina G, Massolo F, Philippe E. Congenital fetal neuroblastoma. Ann Pathol. 2001;21:76-80.
54. Perkins DG, Kopp CM, Haust MD. Placental infiltration in congenital neuroblastoma: a case study with ultrastructure. Histopathology. 1980;4:383-389.
55. Roberts DJ, Nadel A, Lage J, Rutherford CJ. An unusual variant of congenital dyserythropoietic anaemia with mild maternal and lethal fetal disease. Br J Haematol. 1993;84:549-551.
56. Suh YK. Placental pathology casebook: alpha-thalassemia: differential diagnosis. J Perinatol. 1994;14:319-321.
57. Prucka S, Clemens M, Craven C, McPherson E. Single umbilical artery: what does it mean for the fetus? A case-control analysis of pathologically ascertained cases. Genet Med. 2004;6:54-57.
58. Roberts DJ, Ampola MG, Lage JM. Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. Pediatr Pathol. 1991;11: 647-656.
59. Case Records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 23-1997 - a premature newborn infant with congenital ascites. N Engl J Med. 1997;337:260-267.
60. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6:435-448.
61. Redline RW. Placental inflammation. Semin Neonatol. 2004;9:265-274.
62. de Araujo MC, Schultz R, Vaz FA, Massad E, Feferbaum R, Ramos JL. A case-control study of histological chorioamnionitis and neonatal infection. Early Hum Dev. 1994;40:51-58.
63. Holcroft CJ, Askin FB, Patra A, Allen MC, Blakemore KJ, Graham EM. Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus? Am J Obstet Gynecol. 2004;191:2010-2015.
64. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11:18-25.
65. Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183:1124-1129.
66. Altshuler G, Russell P. The human placental villitides: a review of chronic intrauterine infection. Curr Top Pathol. 1975;60:64-112.
67. Pusztai R, Lukacsi A, Kovacs I. Mother-to-fetus transmission of cytomegalovirus: a review. Acta Microbiol Immunol Hung. 2004;51:385-401.
68. Gersell DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol. 1993;10:251-266.
69. Redline RW, Abramowsky CR. Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol. 1985;16:727-731.
70. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol. 1993; 143:473-479.
71. Chan YF, Sampson A. Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole. Aust N Z J Obstet Gynaecol. 2003;43:475-479.
72. Matsui H, Iitsuka Y, Yamazawa K, et al. Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol Int. 2003;53:810-813.
73. Khong TY. Placental vascular development and neonatal outcome. Semin Neonatol. 2004;9:255-263.
74. Gibson BR, Muir-Padilla J, Champeaux A, Suarez ES. Mesenchymal dysplasia of the placenta. Placenta. 2004;25:671-672.
75. Ohyama M, Itani Y, Yamanaka M, et al. Maternal, neonatal, and placental features associated with diffuse chorioamniotic hemosiderosis, with special reference to neonatal morbidity and mortality. Pediatrics. 2004;113:800-805.
76. Robinson HB Jr, Bolande RP. Case 3: fetal hepatoblastoma with placental metastases. Pediatr Pathol. 1985;4:163-167.
77. Doss BJ, Vicari J, Jacques SM, Qureshi F. Placental involvement in congenital hepatoblastoma. Pediatr Dev Pathol. 1998;1:538-542.
78. Las Heras J, Leal G, Haust MD. Congenital leukemia with placental involvement: report of a case with ultrastructural study. Cancer. 1986;58:2278-2281.
79. Alenghat E, Esterly JR. Intravascular hematopoiesis in chorionic villi. Am J Clin Pathol. 1983;79:225-227.
80. Allen AT, Dress AF, Moore WF. Mirror syndrome resulting from metastatic congenital neuroblastoma. Int J Gynecol Pathol. 2007;26:310-312.
81. Schwebke K, Henry K, Balfour HH Jr, Olson D, Crane RT, Jordan MC. Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome. J Pediatr. 1995; 126:293-295.
82. Genest DR, Choi-Hong SR, Tate JE, Qureshi F, Jacques SM, Crum C. Diagnosis of congenital syphilis from placental examination: comparison of histopathology, Steiner stain, and polymerase chain reaction for Treponema pallidum DNA. Hum Pathol. 1996;27:366-372.
83. Yorty JL, Bonneau RH. Transplacental transfer and subsequent neonate utilization of herpes simplex virus-specific immunity are resilient to acute maternal stress. J Virol. 2003;77:6613-6619.
84. Satosar A, Ramirez NC, Bartholomew D, Davis J, Nuovo GJ. Histologic correlates of viral and bacterial infection of the placenta associated with severe morbidity and mortality in the newborn. Hum Pathol. 2004;35:536-545.
85. Chatterjee A, Chartrand SA, Harrison CJ, Felty-Duckworth A, Bewtra C. Severe intrauterine herpes simplex disease with placentitis in a newborn of a mother with recurrent genital infection at delivery. J Perinatol. 2001;21:559-564.
86. Dildy GA III, Moise KJ Jr, Carpenter RJ Jr, Klima T. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv. 1989; 44:535-540.
87. Jackisch C, Louwen F, Schwenkhagen A, et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet. 2003;268:69-77.
88. Folk JJ, Curioca J, Nosovitch JT Jr, Silverman RK. Poorly differentiated large cell adenocarcinoma of the lung metastatic to the placenta: a case report. J Reprod Med. 2004;49:395-397.
89. Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21: 2179-2186.
90. Alexander A, Harris RM, Grossman D, Bruggers CS, Leachman SA. Vulvar melanoma: diffuse melanosis and metastasis to the placenta. J Am Acad Dermatol. 2004;50:293-298.
91. Al-Adnani M, Kiho L, Scheimberg I. Maternal pancreatic carcinoma metastatic to the placenta: a case report and literature review. Pediatr Dev Pathol. 2007;10:61-65.
92. Liu J, Guo L. Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature. Gynecol Oncol. 2006;103:1147-1151.
93. Hogg R, Ungar L, Hazslinszky P. Radical hysterectomy for cervical carcinoma in pregnant women - a case of decidua mimicking metastatic carcinoma in pelvic lymph nodes. Eur J Gynaecol Oncol. 2005;26:499-500.
94. Dessolle L, Dalmon C, Roche B, Menain N, Darai E. Placental metastases from a maternal squamous cell tumor of the maxillary. Eur J Obstet Gynecol Reprod Biol. 2005;123:117-118.
95. Baergen RN, Johnson D, Moore T, Benirschke K. Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med. 1997;121:508-511.
96. Orr JW Jr, Grizzle WE, Huddleston JF. Squamous cell carcinoma metastatic to placenta and ovary. Obstet Gynecol. 1982;59:81S-83S.
97. Potter JF. Metastasis of maternal cancer to placenta and fetus. Am J Obstet Gynecol. 1969;105:645.
98. Antaya RJ, Keller RA, Wilkerson JA. Placental nevus cells associated with giant congenital pigmented nevi. Pediatr Dermatol. 1995;12:260-262.
99. Jauniaux E, de Meeus MC, Verellen G, Lachapelle JM, Hustin J. Giant congenital melanocyte nevus with placental involvement: long-term follow-up of a case and review of the literature. Pediatr Pathol. 1993;13:717-721.
100. Cox JN, Chavrier F. Heterotopic adrenocortical tissue within a placenta. Placenta. 1980;1:131-133.
101. Jacques SM, Qureshi F. Adrenocortical and hepatic nodules within placental tissue. Pediatr Dev Pathol. 2003;6:464-466.
102. Khalifa MA, Gersell DJ, Hansen CH, Lage JM. Hepatic (hepatocellular) adenoma of the placenta: a study of four cases. Int J Gynecol Pathol. 1998;17: 241-244.
103. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med. 1996;16:293-297.
104. Adams-Chapman I, Vaucher YE, Bejar RF, Benirschke K, Baergen RN, Moore TR. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol. 2002; 22:236-241.
105. Gersell DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol. 1993;10:251-266.
106. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG. 2002;109:570-573.